{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:38:33Z","timestamp":1782970713668,"version":"3.54.5"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetic kidney disease is one of the most serious microvascular complications of diabetes. Its pathogenesis is complex, and methods for early diagnosis and intervention are limited, posing major challenges in clinical practice. Exosomes, as key carriers of intercellular communication, are involved in various physiological and pathological processes, such as immune regulation, tumor metastasis, and tissue repair. The regulation of their release is closely related to disease progression and has become a hotspot in research on disease diagnosis and treatment. In diabetic kidney disease, exosomes play a dual role: on the one hand, \u201cpathogenic exosomes\u201d, produced under pathological stimuli such as hyperglycemia, can transmit harmful substances, exacerbating kidney damage, through inflammation and fibrosis; on the other hand, \u201ctherapeutic exosomes\u201d that are derived from stem cells or engineered otherwise, have the potential to protect and repair the kidneys. Previous reviews have predominantly concentrated on the biomarker or therapeutic potential of exosomes in diabetic nephropathy. This paper, however, systematically integrates the multifaceted roles of exosomes in the pathogenesis of diabetic nephropathy and analyses the specific application evidence of exosome-derived biomarkers across various clinical functions. It highlights the dynamic changes in exosomes during disease progression and discusses targeted intervention strategies. Additionally, it examines the opportunities and challenges in clinical translation, aiming to offer novel insights and strategies for the precise diagnosis and targeted treatment of this condition.<\/jats:p>","DOI":"10.3389\/fendo.2026.1831272","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:25:49Z","timestamp":1782966349000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From pathogenic carriers to therapeutic hope: the dual role and translational prospects of exosomes in diabetic kidney disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Fen","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Liuyang People\u2019s Hospital","place":["Liuyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Liuyang People\u2019s Hospital","place":["Liuyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Liuyang People\u2019s Hospital","place":["Liuyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13020-025-01150-w","article-title":"Traditional chinese medicine in diabetic kidney disease: Multifaceted therapeutic mechanisms and research progress","volume":"20","author":"Cai","year":"2025","journal-title":"Chin Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1587806","article-title":"Immune-mediated renal injury in diabetic kidney disease: From mechanisms to therapy","volume":"16","author":"Ma","year":"2025","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1238927","article-title":"Tubular injury in diabetic kidney disease: Molecular mechanisms and potential therapeutic perspectives","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i6.104706","article-title":"Beyond glycemic control: Roles for sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in diabetic kidney disease","volume":"16","author":"Santos","year":"2025","journal-title":"World J Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ph18050670","article-title":"Exploring the protective effects of traditional antidiabetic medications and novel antihyperglycemic agents in diabetic rodent models","volume":"18","author":"Tartau","year":"2025","journal-title":"Pharm (Basel Switzerland)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2025.106557","article-title":"Contemporary management of advanced chronic kidney disease: An evidence-based review","volume":"143","author":"Baker","year":"2026","journal-title":"Eur J Internal Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40620-024-02050-2","article-title":"From bytes to nephrons: AI\u2019s journey in diabetic kidney disease","volume":"38","author":"Basuli","year":"2025","journal-title":"J Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2023.08.006","article-title":"Role of lipid signalling in extracellular vesicles-mediated cell-to-cell communication","volume":"73","author":"Fyfe","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1724600820920293","article-title":"The versatile roles and clinical implications of exosomal mRNAs and microRNAs in cancer","volume":"35","author":"Tang","year":"2020","journal-title":"Int J Biol Markers"},{"key":"B10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12929-023-00964-w","article-title":"Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments","volume":"30","author":"Nail","year":"2023","journal-title":"J BioMed Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2023-0023","article-title":"Exosomal microRNAs: Potential nanotherapeutic targets for diabetic kidney disease","volume":"18","author":"Han","year":"2023","journal-title":"Nanomedicine (London England)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/15353702231151960","article-title":"Therapeutic potentials of stem cell-derived exosomes in cardiovascular diseases","volume":"248","author":"Mani","year":"2023","journal-title":"Exp Biol Med (Maywood NJ)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021205","article-title":"Extracellular vesicles and immunity: At the crossroads of cell communication","volume":"25","author":"Aloi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/boc.70046","article-title":"Exosome tethering requires tetherin homodimerisation","volume":"117","author":"Y\u0131ld\u0131zhan","year":"2025","journal-title":"Biol Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112784","article-title":"Exosomes from different cells: Characteristics, modifications, and therapeutic applications","volume":"207","author":"Li","year":"2020","journal-title":"Eur J Med Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.114305","article-title":"LAMP2A regulates endosomal protein composition and membrane identity in exosome biogenesis","volume":"29","author":"Ferreira","year":"2026","journal-title":"iScience"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41467-024-45753-7","article-title":"Exosomes define a local and systemic communication network in healthy pancreas and pancreatic ductal adenocarcinoma","volume":"15","author":"Adem","year":"2024","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27041927","article-title":"Extracellular vesicles facilitate the crosstalk between high glucose-stimulated mesangial cells and healthy podocytes to mediate injury responses","volume":"27","author":"Novaes","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.168131","article-title":"CD4+ T-cell-derived small extracellular vesicles induce the apoptosis of renal tubular epithelial cells in diabetic nephropathy by regulating mitochondrial dynamics","volume":"1872","author":"Han","year":"2026","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2025.2519817","article-title":"Glomerular mesangial derived extracellular vesicles deteriorate diabetic kidney disease via miR-3147\/PRKAR2B axis","volume":"47","author":"Zhang","year":"2025","journal-title":"Ren Fail"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000550092","article-title":"Mitochondria to the rescue: Organelle trafficking in renal health and disease","volume":"150","author":"Perico","year":"2026","journal-title":"Nephron"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c11423","article-title":"Role of exosomes in cardiovascular disease: A key regulator of intercellular communication in cardiomyocytes","volume":"10","author":"Li","year":"2025","journal-title":"ACS Omega"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.120.16598","article-title":"Urinary and plasma-derived exosomes reveal a distinct microRNA signature associated with albuminuria in hypertension","volume":"77","author":"Perez-Hernandez","year":"2021","journal-title":"Hypertension"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2026.124477","article-title":"Urinary exosomes in diabetic kidney disease: Pathophysiological insights and diagnostic potential","volume":"399","author":"Haripriya","year":"2026","journal-title":"Life Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5c01073","article-title":"Proteome profiling reveals inflammation and fibrosis biomarkers in urinary migrasomes of patients with diabetic kidney disease","volume":"25","author":"Zhou","year":"2026","journal-title":"J Proteome Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2026.103097","article-title":"Dual-targeted engineered mesenchymal stem cell-derived extracellular vesicles delivering Nedd4 attenuate renal fibrosis in diabetic kidney disease","volume":"38","author":"Ji","year":"2026","journal-title":"Mater Today Bio"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/mnh.0000000000001184","article-title":"Mesenchymal\/stromal cell therapy in kidney diseases: An update","volume":"35","author":"Navez","year":"2026","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00292.2020","article-title":"Decreased secretion and profibrotic activity of tubular exosomes in diabetic kidney disease","volume":"319","author":"Wen","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106551","article-title":"Exosomes from high glucose-treated macrophages activate macrophages andinduce inflammatory responses via NF-\u03baB signaling pathway in vitro and in vivo","volume":"84","author":"Zhu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00997-y","article-title":"Proximal tubule- derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer","volume":"21","author":"Tsai","year":"2023","journal-title":"Cell Communication Signaling: CCS"},{"key":"B31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12882-023-03065-w","article-title":"Exosomes from high glucose-treated macrophages promote epithelial-mesenchymal transition of renal tubular epithelial cells via long non-coding RNAs","volume":"24","author":"Yang","year":"2023","journal-title":"BMC Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01655","article-title":"Roles for exosome in various kidney diseases and disorders","volume":"10","author":"Thongboonkerd","year":"2019","journal-title":"Front Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106262","article-title":"The divergent roles of exosomes in kidney diseases: Pathogenesis, diagnostics, prognostics and therapeutics","volume":"149","author":"Thongboonkerd","year":"2022","journal-title":"Int J Biochem Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12967-021-02964-6","article-title":"WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy","volume":"19","author":"Hashemi","year":"2021","journal-title":"J Transl Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2022.2118067","article-title":"Extracellular vesicles metabolic changes reveals plasma signature in stage-dependent diabetic kidney disease","volume":"44","author":"Pan","year":"2022","journal-title":"Ren Fail"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2025.2458767","article-title":"Integration of transcriptome and Mendelian randomization analyses in exploring the extracellular vesicle-related biomarkers of diabetic kidney disease","volume":"47","author":"Yang","year":"2025","journal-title":"Ren Fail"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.830466","article-title":"Integration of metabolomics and proteomics in exploring the endothelial dysfunction mechanism induced by serum exosomes from diabetic retinopathy and diabetic nephropathy patients","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/genes16111328","article-title":"Non-coding RNAs as emerging regulators in kidney pathophysiology: From molecular mechanisms to therapeutic potential","volume":"16","author":"Todorovi\u0107","year":"2025","journal-title":"Genes"},{"key":"B39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41419-021-03460-x","article-title":"HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbaf093","article-title":"Exosome-based Sfrp2 inhibition in mesangial cells alleviates osteoporosis and promotes osteointegration in diabetic kidney disease","volume":"12","author":"Xing","year":"2025","journal-title":"Regener Biomater"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2174\/0115665240287631240321072504","article-title":"Understanding the roles of non-coding RNAs and exosomal non-coding RNAs in diabetic nephropathy","volume":"25","author":"Zhu","year":"2025","journal-title":"Curr Mol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106135","article-title":"Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications","volume":"178","author":"Xu","year":"2022","journal-title":"Pharmacol Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116672","article-title":"Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy","volume":"175","author":"Liu","year":"2024","journal-title":"Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.14715\/cmb\/2023.69.2.7","article-title":"The potential role of exosome-derived mesenchymal stem cells and balanites aEgyptiaca in diabetic nephropathy amelioration in rats","volume":"69","author":"Barakat","year":"2023","journal-title":"Cell Mol Biol (Noisy-Le-Grand France)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13287-022-02855-7","article-title":"MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization","volume":"13","author":"Zhang","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200488r","article-title":"Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial-to- mesenchymal transition via miR-424-5p","volume":"36","author":"Cui","year":"2022","journal-title":"FASEB Journal: Off Publ Fed Am Societies For Exp Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxad010","article-title":"Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through the NLRP3 signaling pathway","volume":"41","author":"Wang","year":"2023","journal-title":"Stem Cells (Dayton Ohio)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302324r","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting hedgehog\/SMO signaling","volume":"38","author":"Zhang","year":"2024","journal-title":"FASEB Journal: Off Publ Fed Am Societies For Exp Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2024.2381597","article-title":"Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through NOD2 signaling pathway","volume":"46","author":"Wang","year":"2024","journal-title":"Renal Failure"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.671566","article-title":"The multi-therapeutic role of MSCs in diabetic nephropathy","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-025-02473-8","article-title":"Beneficial effects of cell-derived exosomes on diabetic nephropathy: A systematic review and meta-analysis of preclinical evidence","volume":"62","author":"Man","year":"2025","journal-title":"Acta Diabetologica"},{"key":"B52","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","article-title":"Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes","volume":"18","author":"Choi","year":"2021","journal-title":"Tissue Eng Regener Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177236","article-title":"Recent advances in the application of engineered exosomes from mesenchymal stem cells for regenerative medicine","volume":"989","author":"Abbasi","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412034","article-title":"Engineered RGD-Treg-Exos targeted delivery of miR-218-5p to activate mitophagy and attenuate podocyte injury in diabetic kidney disease","volume":"12","author":"Guo","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-032-05988-8_268","article-title":"Exosome-based delivery of super-repressor I\u03baB\u03b1 ameliorates kidney ischemia-reperfusion injury","volume":"100","author":"Kim","year":"2021","journal-title":"Kidney Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s529311","article-title":"Exosomes and renal fibrosis: Diagnostic value, therapeutic potential and challenges","volume":"20","author":"Li","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"B57","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s10142-025-01746-3","article-title":"Epigenetic silencing of MSTN via m6A modification underlies the renoprotective effects of engineered MSC exosomes with RBM15 depletion in diabetic nephropathy","volume":"25","author":"Dong","year":"2025","journal-title":"Funct Integr Genomics"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300552","article-title":"Engineering extracellular vesicles as delivery systems in therapeutic applications","volume":"10","author":"Wang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-025-01528-z","article-title":"Engineered extracellular vesicles for treatment of inflammatory diseases","author":"Lu","year":"2025","journal-title":"Mol Biotechnol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/addc41","article-title":"Regeneration of cartilage defects using engineered extracellular vesicles","author":"Samadi","year":"2025","journal-title":"Biofabrication"},{"key":"B61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4239\/wjd.v15.i1.92","article-title":"Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease","volume":"15","author":"Han","year":"2024","journal-title":"World J Diabetes"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2022.2121929","article-title":"Expression of urinary exosomal miRNA-615-3p and miRNA-3147 in diabetic kidney disease and their association with inflammation and fibrosis","volume":"45","author":"Wang","year":"2023","journal-title":"Renal Failure"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00590","article-title":"Urinary exosomal MiRNA-4534 as a novel diagnostic biomarker for diabetic kidney disease","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s11033-025-11015-y","article-title":"The role and therapeutic potential of exosome-mediated microRNAs regulatory networks in diabetic kidney disease","volume":"52","author":"Zhang","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5527\/wjn.v13.i3.99105","article-title":"Reference gene panel for urinary exosome-based molecular diagnostics in patients with kidney disease","volume":"13","author":"Mishra","year":"2024","journal-title":"World J Nephrol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41387-021-00175-y","article-title":"Serum exosomes from diabetic kidney disease patients promote pyroptosis and oxidative stress through the miR-4449\/HIC1 pathway","volume":"11","author":"Gao","year":"2021","journal-title":"Nutr Diabetes"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41419-020-03169-3","article-title":"Exosomal circ_DLGAP4 promotes diabetic kidney disease progression by sponging miR-143 and targeting ERBB3\/NF-\u03baB\/MMP-2 axis","volume":"11","author":"Bai","year":"2020","journal-title":"Cell Death Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12882-025-04360-4","article-title":"Alterations in serum exosomal miR-1207-5p levels reflect severity and progression risk in type 2 diabetic kidney disease","volume":"26","author":"Zhou","year":"2025","journal-title":"BMC Nephrol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/biology12081138","article-title":"Extracellular vesicles: Investigating the pathophysiology of diabetes-associated hypertension and diabetic nephropathy","volume":"12","author":"Alli","year":"2023","journal-title":"Biol (Basel)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150154","article-title":"Urinary exosomal miRNA signature in type II diabetic nephropathy patients","volume":"11","author":"Deli\u0107","year":"2016","journal-title":"PloS One"},{"key":"B71","doi-asserted-by":"publisher","first-page":"23991","DOI":"10.1038\/s41598-025-06002-z","article-title":"Expression and diagnostic value evaluation of urinary exosomal miR-142-3p in diabetic nephropathy","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12882-023-03343-7","article-title":"Urinary exosome proteins PAK6 and EGFR as noninvasive diagnostic biomarkers of diabetic nephropathy","volume":"24","author":"Li","year":"2023","journal-title":"BMC Nephrol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.trsl.2015.05.007","article-title":"Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes","volume":"166","author":"Zubiri","year":"2015","journal-title":"Transl Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041220","article-title":"Urinary exosomal microRNA signatures in nephrotic, biopsy-proven diabetic nephropathy","volume":"9","author":"Lee","year":"2020","journal-title":"J Clin Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12967-019-1983-3","article-title":"The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy","volume":"17","author":"Kim","year":"2019","journal-title":"J Transl Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.2152\/jmi.65.208","article-title":"Urinary exosomal mRNA of WT1 as diagnostic and prognostic biomarker for diabetic nephropathy","volume":"65","author":"Abe","year":"2018","journal-title":"J Med Invest"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216788","article-title":"Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy","volume":"14","author":"Sakurai","year":"2019","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2018.171031","article-title":"Potential value of urinary exosome-derived let-7c-5p in the diagnosis and progression of type II diabetic nephropathy","volume":"64","author":"Li","year":"2018","journal-title":"Clin Lab"},{"key":"B79","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jprot.2013.10.037","article-title":"Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis","volume":"96","author":"Zubiri","year":"2014","journal-title":"J Proteomics"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70238","article-title":"Integrative multi-omics suggests core gene dysregulation of histidine metabolism in diabetic kidney disease","volume":"43","author":"Tan","year":"2026","journal-title":"Diabetes Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.654269","article-title":"Urinary extracellular vesicles as a source of NGAL for diabetic kidney disease evaluation in children and adolescents with type 1 diabetes mellitus","volume":"12","author":"Ugarte","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12038","article-title":"Comparison of urinary extracellular vesicle isolation methods for transcriptomic biomarker research in diabetic kidney disease","volume":"10","author":"Barreiro","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117605","article-title":"Extracellular vesicles in diabetic kidney disease: Emerging mechanisms, therapeutic implications, and biomarker prospects","volume":"244","author":"Yu","year":"2026","journal-title":"Biochem Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7932765","article-title":"miRNAs in urine extracellular vesicles as predictors of early-stage diabetic nephropathy","volume":"2016","author":"Jia","year":"2016","journal-title":"J Diabetes Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2026.2640720","article-title":"Exosomes in diabetic kidney disease: Pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review","volume":"48","author":"Ding","year":"2026","journal-title":"Ren Fail"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.s250347","article-title":"Alpha1-antitrypsin in urinary extracellular vesicles: A potential biomarker of diabetic kidney disease prior to microalbuminuria","volume":"13","author":"Ning","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12967-021-03030-x","article-title":"Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy","volume":"19","author":"Feng","year":"2021","journal-title":"J Transl Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1159\/000539024","article-title":"Role of extracellular vesicle-derived noncoding RNAs in diabetic kidney disease","volume":"10","author":"Hu","year":"2024","journal-title":"Kidney Dis (Basel)"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102046","article-title":"Urinary extracellular vesicles for diabetic kidney disease diagnosis","volume":"10","author":"Saenz-Pipaon","year":"2021","journal-title":"J Clin Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154834","article-title":"Exosomes: Advances, development and potential therapeutic strategies in diabetic nephropathy","volume":"122","author":"Chen","year":"2021","journal-title":"Metabolism"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.149156","article-title":"Autocrine small extracellular vesicles induce tubular phenotypic transformation in diabetic nephropathy via miR-21-5p","volume":"938","author":"Zhang","year":"2025","journal-title":"Gene"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1031","article-title":"Exocytosis-mediated urinary full-length megalin excretion is linked with the pathogenesis of diabetic nephropathy","volume":"66","author":"De","year":"2017","journal-title":"Diabetes"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111034","article-title":"Podocyte-derived extracellular vesicles mediate renal proximal tubule cells dedifferentiation via microRNA-221 in diabetic nephropathy","volume":"518","author":"Su","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2337\/db18-1360","article-title":"Diabetic nephropathy alters the distribution of circulating angiogenic microRNAs among extracellular vesicles, HDL, and Ago-2","volume":"68","author":"Florijn","year":"2019","journal-title":"Diabetes"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.194604","article-title":"MYO1C is a urinary extracellular vesicle biomarker and mediator of podocyte injury in diabetic nephropathy","volume":"11","author":"Zhao","year":"2026","journal-title":"JCI Insight"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2024.0093","article-title":"Standardized reporting of research on exosomes to ensure rigor and reproducibility","volume":"13","author":"Yadav","year":"2024","journal-title":"Adv Wound Care"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-022-04174-5","article-title":"A review on comparative studies addressing exosome isolation methods from body fluids","volume":"415","author":"Martins","year":"2023","journal-title":"Anal Bioanal Chem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13122970","article-title":"Human blood exosomes: Isolation and characterization methods, variability, and the need for standardized protocols-a review","volume":"13","author":"Mengual","year":"2025","journal-title":"Biomedicines"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/nano10050971","article-title":"Selected tetraspanins functionalized niosomes as potential standards for exosome immunoassays","volume":"10","author":"Garc\u00eda-Manrique","year":"2020","journal-title":"Nanomaterials (Basel Switzerland)"},{"key":"B100","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hcs2.70028","article-title":"Exploring regulatory frameworks for exosome therapy: Insights and perspectives","volume":"4","author":"Li","year":"2025","journal-title":"Health Care Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13904","article-title":"Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes","volume":"17","author":"Wang","year":"2024","journal-title":"Clin Transl Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1677088","article-title":"Exosomal biomarkers in leukemia: Translational potential and regulatory challenges for precision medicine applications","volume":"16","author":"Ansarian","year":"2025","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073742","article-title":"Standard radio-iodine labeling protocols impaired the functional integrity of mesenchymal stem\/stromal cell exosomes","volume":"25","author":"Yang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.866252","article-title":"A systematic review and meta-analysis of urinary extracellular vesicles proteome in diabetic nephropathy","volume":"13","author":"Ding","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/resp.13756","article-title":"Extracellular vesicles","volume":"94","author":"Gon\u00e7alves","year":"2024","journal-title":"Curr Top Membr"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.2c00207","article-title":"Multiparametric biosensors for characterizing extracellular vesicle subpopulations","volume":"6","author":"Shaabani","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1042\/ebc20170088","article-title":"Exosomes and extracellular vesicles: the path forward","volume":"62","author":"Stahl","year":"2018","journal-title":"Essays Biochem"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v2i0.20920","article-title":"Extracellular vesicle (EV) array: microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping","volume":"2","author":"J\u00f8rgensen","year":"2013","journal-title":"J Extracell Vesicles"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/mas.21420","article-title":"Proteomics of extracellular vesicles: exosomes and ectosomes","volume":"34","author":"Choi","year":"2015","journal-title":"Mass Spectrom Rev"},{"key":"B110","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2024.12.005","article-title":"Canagliflozin inhibits hedgehog interacting protein (Hhip) induction of tubulopathy in diabetic Akita mice","volume":"277","author":"Chang","year":"2025","journal-title":"Transl Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-021-00710-5","article-title":"Characterization of pendrin in urinary extracellular vesicles in a rat model of aldosterone excess and in human primary aldosteronism","volume":"44","author":"rOchiai-Homma","year":"2021","journal-title":"Hypertens Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/ijd.17903","article-title":"Exosomes in dermatology: a comprehensive review of current applications, clinical evidence, and future directions","volume":"64","author":"Nahm","year":"2025","journal-title":"Int J Dermatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1590\/1519-6984.271731","article-title":"Amelioration of exosome and mesenchymal stem cells in rats infected with diabetic nephropathy by attenuating early markers and aquaporin-1 expression","volume":"83","author":"Zahran","year":"2023","journal-title":"Braz J Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202100359","article-title":"Exosomes as targeted delivery platform of CRISPR\/Cas9 for therapeutic genome editing","volume":"22","author":"Duan","year":"2021","journal-title":"ChemBioChem"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000875","article-title":"Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic kras G12D in pancreatic cancer","volume":"4","author":"McAndrews","year":"2021","journal-title":"Life Sci Alliance"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155785","article-title":"Exosome-mediated delivery of CRISPR-Cas9: a revolutionary approach to cancer gene editing","volume":"266","author":"Balaraman","year":"2025","journal-title":"Pathol Res Pract"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1831272\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:25:51Z","timestamp":1782966351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1831272\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":116,"alternative-id":["10.3389\/fendo.2026.1831272"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1831272","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1831272"}}